Isolated lung perfusion for patients with unresectable metastases from sarcoma: A phase I trial

Annals of Thoracic Surgery

Volumn 69, Issue 5, 2000, Pages 1542-1549

  Burt, Michael E ^a   Liu, David ^a   Abolhoda, Amir ^a   Ross, Howard M ^a   Kaneda, Yoshikazu ^a   Jara, Ellen ^a   Casper, Ephraim S ^a   Ginsberg, Robert J ^a   Brennan, Murray F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HEART EJECTION FRACTION; HUMAN; ISOLATED LUNG; LUNG DIFFUSION CAPACITY; LUNG METASTASIS; LUNG PERFUSION; LUNG SCINTISCANNING; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SARCOMA; SURVIVAL RATE;

ADULT; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DOXORUBICIN; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; SARCOMA;

EID: 0033919522     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(00)01131-0     Document Type: Article

References (27)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics, 1998. CA Cancer J Clin. 48:1998;6-29.
2. Potter D.A., Glenn J., Kinsella T., et al. Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol. 3:1985;353-366.
3. Jablons D., Steinberg S.M., Roth J., Pittaluga S., Rosenberg S.A., Pass H.I. Metastasectomy for soft tissue sarcoma. Further evidence for efficacy and prognostic indicators. J Thorac Cardiovasc Surg. 97:1989;695-705.
4. Casson A.G., Putnam J.B., Natarajan G., et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer. 69:1992;662-668.
5. Verazin G.T., Warneke J.A., Driscoll D.L., Karakousis C., Petrelli N.J., Takita H. Resection of lung metastases from soft-tissue sarcomas. A multivariate analysis. Arch Surg. 127:1992;1407-1411.
6. Gadd M.A., Casper E.S., Woodruff J.M., McCormack P.M., Brennan M.F. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg. 218:1993;705-712.
7. Glenn J., Kinsella T., Glatstein E., et al. A randomized, prospective trial of adjuvant chemotherapy in adults with soft tissue sarcomas of the head and neck, breast, and trunk. Cancer. 55:1985;1206-1214.
8. Omura G.A., Major F.J., Blessing J.A., et al. A randomized study of Adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer. 52:1983;626-632.
9. Lerner H.J., Amato D.A., Savlov E.D., et al. A comparison of adjuvant doxorubicin and observation for patients with localized soft tissue sarcoma. J Clin Oncol. 5:1987;613-617.
10. Chang A.E., Kinsella T., Glatstein E., et al. Adjuvant chemotherapy for patients with high-grade soft-tissue sarcomas of the extremity. J Clin Oncol. 6:1988;1491-1500.
11. Rosenberg S.A. Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomas. Cancer Treat Rep. 68:1984;1067-1078.
12. Rosenberg S.A., Tepper J., Glatstein E., et al. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities. Cancer. 52:1983;424-434.
13. Weksler B., Ng B., Lenert J.T., Burt M.E. Isolated single-lung perfusion with doxorubicin is pharmacokinetically superior to intravenous injection. Ann Thorac Surg. 56:1993;209-214.
14. Weksler B., Lenert J., Ng B., Burt M. Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model. J Thorac Cardiovasc Surg. 107:1994;50-54.
15. Barney J.D., Churchill E.D. Adenocarcinoma of the kidney with metastases to the lung cured by nephrectomy and lobectomy. J Urol. 42:1939;269-276.
16. Long-term results of lung metastasectomy prognostic analyses based on 5206 cases . J Thorac Cardiovasc Surg. 113:1997;37-49.
17. Rizzoni W.E., Pass H.I., Wesley M.N., Rosenberg S.A., Roth J.A. Resection of recurrent pulmonary metastases in patients with soft-tissue sarcomas. Arch Surg. 121:1986;1248-1252.
18. Huth J.F., Holmes E.C., Vernon S.E., et al. Pulmonary resection for metastatic sarcoma. Am J Surg. 140:1980;9-16.
19. Wheeler R.H., Ensminger W.D., Thrall J.H., Anderson J.L. High-dose doxorubicin an exploration of the dose-response curve in human neoplasia . Cancer Treat Rep. 66:1982;493-498.
20. Calabresi P., Chabner B.A. Chemotherapy of neoplastic disease. Gilman A.G., Rall T.W., Nies A.S., Taylor P. Goodman and Gilman's the pharmacological basis of therapeutics. 1990;1209-1263 Pergamon, New York.
21. Casper E.S., Gaynor J.J., Hajdu S.I., et al. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors. Cancer. 68:1991;1221-1229.
22. Creech O., Krementz E.T., Ryan R.F., Winblad J.N. Chemotherapy of cancer regional perfusion utilizing an extracorporeal circuit . Ann Surg. 148:1958;616-632.
23. Minchin R.F., Johnston M.R., Schuller H.M., Aiken M.A., Boyd M.R. Pulmonary toxicity of doxorubicin administered by in situ isolated lung perfusion in dogs. Cancer. 61:1988;1320-1325.
24. Baciewicz F.A. Jr, Arredondo M., Chaudhuri B., et al. Pharmacokinetics and toxicity of isolated perfusion of lung with doxorubicin. J Surg Res. 50:1991;124-128.
25. Minchin R.F., Johnston M.R., Aiken M.A., Boyd M.R. Pharmacokinetics of doxorubicin in isolated lung of dogs and humans perfused in vivo. J Pharmacol Exp Ther. 229:1984;193-198.
26. Johnston M.R., Minchen R.F., Dawson C.A. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg. 110:1995;368-373.
27. Ohno T. Bronchial artery infusion with anticancer agents in the treatment of osteosarcoma prevention of pulmonary metastasis and improvement of prognosis . Cancer. 27:1971;549-557.